bpc 157 or BPC-157 – Research Peptide BPC-157 for athletes and injury

Unlike many endogenous peptides that degrade rapidly in the gastrointestinal tract, BPC-157 exhibits unusual stability, making it a robust subject for in vitro and in vivo laboratory investigations

While most nootropics work by tweaking neurotransmitters or improving blood flow, Dihexa takes a different approach

His reports also point to it aiding in musculoskeletal and gastrointestinal repair

doi: 10.1096/fba.2024-00151 Dacquin R, Davey RA, Laplace C, et al

Most users report noticeable pain reduction within 5 to 10 days, with significant functional improvement occurring between weeks 2 and 4 of administration